Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn New India Regulatory News (ANII)

Share Price Information for Abrdn New India (ANII)

Share Price is delayed by 15 minutes
Get Live Data
670.00    8.00 (1.21%)
Bid:
654.00
Ask:
674.00
Spread: 20.00 (3.058%)
Market Cap: £290.36m
ANII Live PriceLast checked at - London Stock Exchange

Intraday Abrdn New India Share Chart

Directorate Changes

1 Apr 2026 07:00

RNS Number : 9243Y
Aberdeen New India Investment Trust
01 April 2026
 

ABERDEEN NEW INDIA INVESTMENT TRUST PLC

LEI - 549300D2AW66WYEVKF02

 

 

1 April 2026

 

Appointment of Non-Executive Director

 

The Board of Aberdeen New India Investment Trust PLC (the "Company") is pleased to announce the appointment of Francesca Ecsery as an independent non-executive Director of the Company with effect from 1 April 2026 following a search conducted by an independent recruitment consultancy.

 

Francesca Ecsery has over 30 years' experience working in both blue-chip companies and start-ups and has special expertise in multiplatform consumer marketing, branding and commercial strategies. She is a non-executive director of Haffner Energy S.A., Air France S.A. and Henderson High Income Trust plc.

 

Francesca was previously a non-executive director at F&C Investment Trust PLC, the Association of Investment Companies (AIC), Marshall Motor Holdings PLC, Share PLC and Good Energy Group PLC and has held various senior positions in consumer-focused industries including the digital, retail and leisure and travel sectors. Her previous executive roles include McKinsey, PepsiCo, Thorn EMI, Thomas Cook and STA Travel.

 

There are no other disclosures required to be made for Francesca Ecsery in respect of paragraphs UKLR 6.4.8R (1) - (6) of the Financial Conduct Authority's Listing Rules.

 

Francesca Ecsery, or her persons closely associated, has no interest in the shares of the Company.

 

Appointment of Chairman and Senior Independent Director

 

As set out in the Annual Report for the year ended 31 March 2025, Michael Hughes retired as Chairman of the Board and as a Director of the Company on 31 March 2026.

 

With effect from 1 April 2026, David Simpson is appointed Chairman of the Board, Andrew Robson is appointed Senior Independent Director and Irina Miklavchich is appointed Chair of the Management Engagement Committee.

 

 

For further information, please contact:

 

Stuart Reid

abrdn Holdings Limited

Secretaries

 

Email:  cef.cosec@aberdeenplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAJBMFTMTBJBRF
Date   Source Headline
10th Feb 20255:19 pmRNSTransaction in Own Shares
10th Feb 20253:15 pmRNSGearing disclosure
10th Feb 20251:10 pmRNSNet Asset Value(s)
7th Feb 20255:10 pmRNSTransaction in Own Shares
7th Feb 202511:49 amRNSNet Asset Value(s)
6th Feb 20255:13 pmRNSTransaction in Own Shares
6th Feb 20252:37 pmRNSMonth End Net Asset Value(s)
6th Feb 202512:55 pmRNSNet Asset Value(s)
5th Feb 20255:24 pmRNSTransaction in Own Shares
5th Feb 202511:55 amRNSNet Asset Value(s)
4th Feb 20255:33 pmRNSTransaction in Own Shares
4th Feb 202512:47 pmRNSNet Asset Value(s)
3rd Feb 20255:31 pmRNSTransaction in Own Shares
3rd Feb 20253:03 pmRNSGearing disclosure
3rd Feb 202510:42 amRNSTotal Voting Rights
31st Jan 20255:12 pmRNSTransaction in Own Shares
31st Jan 20253:40 pmRNSHolding(s) in Company
31st Jan 202512:19 pmRNSNet Asset Value(s)
30th Jan 20255:13 pmRNSTransaction in Own Shares
30th Jan 202512:57 pmRNSNet Asset Value(s)
29th Jan 20255:10 pmRNSTransaction in Own Shares
29th Jan 202512:41 pmRNSNet Asset Value(s)
28th Jan 20255:29 pmRNSTransaction in Own Shares
28th Jan 202512:22 pmRNSNet Asset Value(s)
27th Jan 20255:15 pmRNSTransaction in Own Shares
27th Jan 20251:24 pmRNSGearing disclosure
27th Jan 202512:46 pmRNSNet Asset Value(s)
24th Jan 20255:21 pmRNSTransaction in Own Shares
24th Jan 202512:32 pmRNSNet Asset Value(s)
23rd Jan 20255:19 pmRNSTransaction in Own Shares
23rd Jan 202512:33 pmRNSNet Asset Value(s)
22nd Jan 20255:17 pmRNSTransaction in Own Shares
22nd Jan 202512:30 pmRNSNet Asset Value(s)
21st Jan 20255:23 pmRNSTransaction in Own Shares
21st Jan 20253:22 pmRNSHolding(s) in Company
21st Jan 202512:34 pmRNSNet Asset Value(s)
20th Jan 20255:19 pmRNSTransaction in Own Shares
20th Jan 202512:05 pmRNSGearing disclosure
20th Jan 202511:44 amRNSNet Asset Value(s)
17th Jan 20255:06 pmRNSTransaction in Own Shares
17th Jan 202511:52 amRNSNet Asset Value(s)
16th Jan 20255:14 pmRNSTransaction in Own Shares
16th Jan 20253:23 pmRNSDirector/PDMR Shareholding
16th Jan 20251:05 pmRNSNet Asset Value(s)
15th Jan 20255:12 pmRNSTransaction in Own Shares
15th Jan 202511:51 amRNSNet Asset Value(s)
14th Jan 20255:09 pmRNSTransaction in Own Shares
14th Jan 202512:17 pmRNSNet Asset Value(s)
13th Jan 20255:10 pmRNSTransaction in Own Shares
13th Jan 20251:00 pmRNSGearing disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.